“Clinical trial evidence that informs care focuses primarily on preventing future events, optimizing disease-specific outcomes, or extending survival. These outcomes are defined by investigators, not by patients who vary in the outcomes that matter most to them,” write the authors of a new JAMA Internal Medicine Viewpoint, Mary Tinetti, Melissa Hladek, and Deborah Ejem, PhD, MA. Addressing health inequities begins by recognizing the uncertain benefit of many guidelines-driven interventions, the variable health priorities of individuals, and the importance of currently considered non-medical interventions. 👉 Read the full story here: https://lnkd.in/eNMaTmUF 📚 Read the publication: https://lnkd.in/eyJHYP8M The John A. Hartford Foundation Yale Department of Internal Medicine Johns Hopkins School of Nursing University of Alabama at Birmingham #healthinequalities #healthequity #healthcare #patientcentricity #healthpriorities
